Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein e ε4, and the risk of late-onset Alzheimer disease in African Americans

JAMA

Volumn 309, Issue 14, 2013, Pages 1483-1492

  Reitz, Christiane ^a,b   Jun, Gyungah ^c,d   Naj, Adam ^f   Rajbhandary, Ruchita ^f   Vardarajan, Badri Narayan ^c,d   Wang, Li San ^g   Valladares, Otto ^g   Lin, Chiao Feng ^g   Larson, Eric B ^h,j   Graff Radford, Neill R ^k,l   Evans, Denis ^m   De Jager, Philip L ^p,q,r   Crane, Paul K ^h   Buxbaum, Joseph D ^v   Murrell, Jill R ^s   Raj, Towfique ^q   Ertekin Taner, Nilufer ^k,l   Logue, Mark ^c   Baldwin, Clinton T ^c   Green, Robert C ^q   Barnes, Lisa L ⁿ   Cantwell, Laura B ^g   Fallin, M Daniele ^w   Go, Rodney C P ^x   Griffith, Patrick ^y   Obisesan, Thomas O ^z   Manly, Jennifer J ^a   Lunetta, Kathryn L ^d   Kamboh, M Ilyas ^aa   Lopez, Oscar L ^aa   Bennett, David A ^n,o   Hendrie, Hugh ^t,u,ae   Hall, Kathleen S ^u   Goate, Alison M ^ab   Byrd, Goldie S ^ac   Kukull, Walter A ⁱ   Foroud, Tatiana M ^s   Haines, Jonathan L ^ad   Farrer, Lindsay A ^c,d,e   Pericak Vance, Margaret A ^f   Schellenberg, Gerard D ^g   Mayeux, Richard ^a,b   more..

^a Columbia University ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j GROUP HEALTH RESEARCH INSTITUTE   (United States)

^k MAYO GRADUATE SCHOOL   (United States)

^l MAYO CLINIC   (United States)

^m RUSH UNIVERSITY MEDICAL CENTER   (United States)

ⁿ RUSH UNIVERSITY MEDICAL CENTER   (United States)

^o RUSH UNIVERSITY MEDICAL CENTER   (United States)

^p BRIGHAM AND WOMEN S HOSPITAL   (United States)

^q HARVARD MEDICAL SCHOOL   (United States)

^r BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^s INDIANA UNIVERSITY   (United States)

^t INDIANA UNIVERSITY CENTER FOR AGING RESEARCH   (United States)

^u INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^w JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^x UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^y MEHARRY MEDICAL COLLEGE   (United States)

^z HOWARD UNIVERSITY HOSPITAL   (United States)

^aa UNIVERSITY OF PITTSBURGH   (United States)

^ab WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ac NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^ad VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ae REGENSTRIEF INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CYTOSINE; GUANINE;

ABCA7 GENE; ADULT; AFRICAN AMERICAN; AGED; ALZHEIMER DISEASE; APOE GENE; ARTICLE; BIN1 GENE; CD33 GENE; CONTROLLED STUDY; CR1 GENE; EPHA1 GENE; ETHNIC GROUP; EUROPEAN; FAMILY STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); ONSET AGE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84875922261     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.2973     Document Type: Article

References (53)

1. Fratiglioni L, De Ronchi D, Agüero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 1999;15(5):365-375.
2. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol. 1998;55(7):964-968.
3. Hollingworth P, Harold D, Sims R, et al Alzheimer's Disease Neuroimaging Initiative; CHARGE Consortium; EADI1 Consortium. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011;43(5):429-435.
4. Lambert JC, Heath S, Even G, et al European Alzheimer's Disease Initiative Investigators. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41(10):1094- 1099.
5. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011;43(5):436-441.
6. Seshadri S, Fitzpatrick AL, Ikram MA, et al CHARGE Consortium; GERAD1 Consortium; EADI1 Consortium. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832-1840.
7. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41(10):1088-1093.
8. Reitz C, Cheng R, Rogaeva E, et al; Genetic and Environmental Risk in Alzheimer Disease 1 Consortium. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol. 2011;68(1):99-106.
9. Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet . 2007;39(2):168-177.
10. Gatz M, Pedersen NL, Berg S, et al. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci . 1997;52(2):M117-M125.
11. Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56(1):49-56.
12. Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279(10):751-755.
13. Barnes LL, Shah RC, Aggarwal NT, Bennett DA, Schneider JA. The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia. Curr Alzheimer Res. 2012;9(6):734-745.
14. Beecham GW, Martin ER, Li YJ, et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet. 2009;84(1):35-43.
15. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64(5):834-841.
16. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon C, Bienias JL, Wilson RS. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005;25(4):163-175.
17. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59(2):198-205.
18. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 1998;55(3):326-335.
19. Bienias JL, Beckett LA, Bennett DA, Wilson RS, Evans DA. Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis. 2003;5(5):349-355.
20. Carrasquillo MM, Zou F, Pankratz VS, et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet. 2009;41(2):192-198.
21. Edwards TL, Scott WK, Almonte C, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet. 2010;74(2):97-109.
22. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003;60(2):185-189.
23. Green RC, Cupples LA, Go R, et al MIRAGE Study Group. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA. 2002;287(3):329-336.
24. Haroutunian V, Perl DP, Purohit DP, et al. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol. 1998;55(9):1185-1191.
25. Jun G, Naj AC, Beecham GW, et al Alzheimer's Disease Genetics Consortium. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010;67(12):1473-1484.
26. Kamboh MI, Minster RL, Demirci FY, et al. Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol Aging . 2012;33(3):518-521.
27. Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002;59(11):1737-1746.
28. Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R; National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol. 2008;65(11):1518-1526.
29. Logue MW, Schu M, Vardarajan BN, et al Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study Group. A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol. 2011;68(12):1569-1579.
30. Morris JC, Roe CM, Xiong C, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol . 2010;67(1):122-131.
31. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis Assoc Disord. 2006;20(4):210-216.
32. Murrell JR, Price B, Lane KA, et al. Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Arch Neurol. 2006;63(3):431-434.
33. Scott WK, Nance MA, Watts RL, et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA. 2001;286(18):2239-2244.
34. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology. 2006;67(3):467-473.
35. Meier IB, Manly JJ, Provenzano FA, et al. White matter predictors of cognitive functioning in older adults. J Int Neuropsychol Soc. 2012;18(3):414-427.
36. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
37. US Census Bureau. 1990 Census of Population and Housing Summary File 1. Washington, DC: US Census Bureau; 1991.
38. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques. 1997;22(1):176-181.
39. Ahmadian A, Gharizadeh B, Gustafsson AC, et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem. 2000;280(1):103-110.
40. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545-548.
41. Lai E, Riley J, Purvis I, Roses A. A 4-mb high-density single nucleotide polymorphism-based map around human APOE. Genomics. 1998;54(1):31-38.
42. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904-909.
43. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012;44(8):955-959.
44. Chanda P, Yuhki N, Li M, et al. Comprehensive evaluation of imputation performance in African Americans. J Hum Genet. 2012;57(7):411-421.
45. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
46. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
47. Liu JZ, McRae AF, Nyholt DR, et al AMFS Investigators. A versatile gene-based test for genome-wide association studies. Am J Hum Genet. 2010;87(1):139-145.
48. Tanaka N, Abe-Dohmae S, Iwamoto N, Yokoyama S. Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system. J Atheroscler Thromb. 2011;18(4):274-281.
49. Chan SL, Kim WS, Kwok JB, et al. ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem. 2008;106(2):793-804.
50. Roger VL, Go AS, Lloyd-Jones DM, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation . 2012;125(1):e2-e220.
51. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000;21(2):153-160.
52. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease, I: review of epidemiological and preclinical studies. Arch Neurol. 2011;68(10):1239-1244.
53. Hancock DB, Levy JL, Gaddis NC, et al. Assessment of genotype imputation performance using 1000 Genomes in African American studies. PLoS One. 2012;7(11):e50610.